Marketing-authorisation holder

Microbix Biosystems Inc.

3 medicines2 countries

3 medicines in 2 countries, as authorisation holder.

Medicines

Every medicine in the registers under its name, current ones first.

3 medicines

Medicine	Substance	Country	Status	Authorised
KINLYTIC250,000 iu/vial \| 5,000 iu/vial \| 9,000 iu/vial · Injectable	Urokinase	United States	Not marketed	1978
KINLYTIC OPEN-CATH5000 unit / vial · Powder For Solution	Urokinase	Canada	Cancelled	1991
KINLYTIC (UROKINASE FOR INJECTION)250000 unit / vial · Powder For Solution	Urokinase	Canada	Cancelled	1988

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Canada	2	0	2	Companies All medicines
United States	1	1	0	Companies All medicines

The ATC groups most of its medicines belong to, largest first.

The active substances in most of its medicines.

How the registers spell it, normalised: legal forms, accents and capitals removed.

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions

Report an error or request removalCorrections from the company itself are welcome.